Teva Pharmaceutical Industries Ltd
- Stock
- Ticker TEVA
- ISIN IL0006290147
- NYSE
- US listing in dollars
Performance, volatility and drawdowns of Teva Pharmaceutical Industries Ltd since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $10,484. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −83.5% in 08/2019, measured from the peak in 11/2016. It took 117 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 4,229 | 3,891 | 4,176 | 4,480 | 1,500 | 3,982 | 4,142 | 4,395 |
| Gross profit | 2,121 | 1,877 | 2,102 | 2,304 | 2,656 | 1,972 | 2,153 | 2,440 |
| Operating income | -29 | 519 | 455 | 882 | 300 | 652 | -231 | 714 |
| EBITDA | 240 | 763 | 706 | 1,131 | 560 | 891 | 10 | 959 |
| Net income | -217 | 214 | 282 | 433 | 480 | 369 | -576 | 233 |
| Earnings per share | -0.19 | 0.18 | 0.24 | 0.37 | 0.41 | 0.31 | -0.49 | 0.20 |
| Balance sheet | ||||||||
| Total assets | 39,326 | 38,415 | 40,131 | 39,856 | 40,748 | 40,040 | 39,857 | 40,042 |
| Liabilities | 33,606 | 32,146 | 33,297 | 32,602 | 32,834 | 31,809 | 32,100 | 32,057 |
| Equity | 5,373 | 6,262 | 6,827 | 7,250 | 7,910 | 8,228 | 7,753 | 7,979 |
| Cash | 3,300 | 1,697 | 2,161 | 2,203 | 3,556 | 3,741 | 3,655 | 4,085 |
| Cash flow | ||||||||
| Operating cash flow | 575 | -105 | 227 | 369 | 1,158 | -40 | 411 | 241 |
| Capital expenditure | -129 | -127 | -96 | -136 | -142 | -168 | -104 | -120 |
| Free cash flow | 446 | -232 | 131 | 233 | 1,016 | -208 | 307 | 121 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2024 at +111.1%, weakest 2017 at −46.2%. 4 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 3 Nov 2026 | $0.20 |
| 29 Jul 2026 | −$0.49 |
| 29 Apr 2026 | $0.31 |
| 3 Feb 2026 | $0.41 |
| 5 Nov 2025 | $0.37 |
| 30 Jul 2025 | $0.24 |
| 7 May 2025 | $0.18 |
| 5 Feb 2025 | −$0.19 |
| 6 Nov 2024 | −$0.39 |
| 31 Jul 2024 | −$0.75 |
| 8 May 2024 | −$0.12 |
| 12 Feb 2024 | $0.41 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €41bn
- Market cap in trading currency
- $45.8bn
- Enterprise value
- $45.7bn
- P/E
- 91.2
- P/S
- 3.27
- P/B
- 5.74
- EV/Sales
- 3.26
- EV/EBITDA
- 18.9
- Earnings yield
- 1.1%
- FCF yield
- 2.7%
Results (last four quarters)
- Revenue
- $14.0bn
- Gross profit
- $9.22bn
- EBITDA
- $2.42bn
- Net income
- $506m
- Earnings per share
- $0.43
- Revenue per share
- $12.01
- Revenue growth
- −1.9%
- Earnings growth
- −46.2%
Profitability
- Gross margin
- 65.8%
- Operating margin
- 10.2%
- Net margin
- 3.6%
- Return on equity
- 6.6%
- Return on assets
- 1.3%
Balance sheet and cash flow
- Cash
- $4.09bn
- Cash per share
- $3.50
- Financial debt
- $4.04bn
- Debt/equity %
- 51
- Current ratio
- 0.95
- Book value per share
- $6.84
- Operating cash flow
- $1.77bn
- Free cash flow
- $1.24bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 1.17bn
- Volume
- 6.81m
- Avg. volume 3 months
- 6.13m
- Relative volume
- 1.1
Price and technicals
- Price
- $39.23
- 1 day
- +1.8%
- 52-week high
- $44.50
- 52-week low
- $24.21
- Distance to 52-week high
- −11.8%
- Distance to 52-week low
- +62.0%
- Distance to 50-day line
- −3.4%
- Distance to 200-day line
- +11.3%
- RSI (14)
- 40
- Volatility 1M
- 45.7%
Performance
- 1 week
- −11.8%
- 1 month
- −2.4%
- 3 months
- +6.2%
- 6 months
- +15.1%
- YTD
- +25.7%
- 1 year
- +60.5%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has TEVA performed since 11/2016?
$10,000 grew to $10,484 by 20 Nov 2026, which is +0.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is TEVA?
Volatility was 46.8% per year, measured on monthly returns. The largest decline from a peak was −83.5%, with the low in 08/2019.
How does TEVA compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, TEVA returned +0.5% at 46.8%. The correlation of monthly returns was 0.37; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.
Why does this page show a US listing?
The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.